Download Dear BSH Member, On behalf of the Programme Committee of the

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Management of acute coronary syndrome wikipedia , lookup

Saturated fat and cardiovascular disease wikipedia , lookup

Remote ischemic conditioning wikipedia , lookup

Cardiovascular disease wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Electrocardiography wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Coronary artery disease wikipedia , lookup

Rheumatic fever wikipedia , lookup

Congenital heart defect wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Heart failure wikipedia , lookup

Transcript
Dear BSH Member,
On behalf of the Programme Committee of the British Cardiovascular Society, I am delighted to be
building the programme for the BCS Annual Conference, 8 – 10 June 2015 in Manchester. The aim
of this mailshot is to highlight the heart failure content of the meeting to BSH members, although of
course it is likely that as many heart failure specialists will attend the meeting for the “non-heart
failure” aspects of the meeting as for the “heart-failure” aspects.
The theme of the 2015 programme is ‘Hearts
and Genes’, and we are delighted to announce
that Professor Robert Winston will be giving this
year’s Opening Ceremony Keynote Speech,
entitled “Where are we going with molecular
medicine?" This will be followed by a new-style
BHF “gene-to-bedside” session focussing on
Hypertrophic Cardiomyopathy (facilitated by
Professor Hugh Watkins) and BHF/UKGTN
sessions on the new gene panels for diagnosis
of inherited cardiovascular disease.
Sessions of particular note to those with an
interest in heart failure include:
Prof Robert Winston
Emerging medical treatment of valve disease:
Monday, 10:45 - 12:15
Chairs: Dr Bernard Prendergast and Dr Gerry McCann
Talks:




Prof Hugh Watkins
Aortic stenosis; a disease of calcium homeostasis? - Prof Catherine Otto
ACE inhibitors for aortic valve disease? - Prof Chim Lang
Drug treatment of acute heart failure in aortic stenosis? - Prof John Chambers
Pulmonary hypertension after left sided surgery - Dr Gerry Coghlan
Update in acute heart failure: Monday, 10:45 - 12:15
Chairs: Dr Mamas Mamas and Prof Iain Squire
Talks:



What is acute heart failure? - Prof Andrew Clark
Trials of acute heart failure therapy - Prof John McMurray
National heart failure audit - Prof Theresa McDonagh

NICE guidance in Acute Heart Failure - Dr Suzanna Hardman
Innovations in heart failure therapy: Monday, 13:45 - 14:45
Chairs: Dr Alexander Lyon and Dr Simon Williams
Talks:


Telemonitoring for heart failure - Prof Martin Cowie
Vagal stimulation: nectar for heart failure? - Dr Jay Wright
Prof Andrew Clarke

Stem cell therapy for heart failure - Prof Anthony Mathur
Heart Failure in the U.K. – How are we doing?: Monday, 16:00 - 17:00
Chairs: Prof Andrew Clark and Dr Mamas Mamas
Talks:



Treating acute heart failure: New NICE guidance - Prof Martin Cowie
Managing chronic heart failure: A new paradigm? - Prof John McMurray
Reducing heart failure readmissions - Dr Simon Woldman
Prof John McMurray
The heart in systemic disease: Monday, 16:00 - 17:00
Chairs: Dr Sara Thorne and Dr Sarah Clarke
Talks:


Amyloid and the heart - Dr Simon Dubrey
Malignancy and the heart - Prof Simon Ray
Innovations in Cardio-Oncology: Monday, 16:00 - 17:00
Chairs: Dr Alexander Lyon and Dr Stuart Rosen
Talks:



Translational insights into anthracycline cardiotoxicity - Dr Kim Linton
New therapeutic strategies to protect the heart from cancer drugs - Dr Helen Maddock
Surveillance with cardiac biomarkers to predict cardiotoxicity - Dr Daniel Lenihan
Innovations in the diagnosis and treatment of cardiomyopathies: Wednesday, 08:30 - 09:30
Chairs: Dr Costas O'Mahony and Prof Hugh Watkins
Talks:




New insights into pathogenesis and risk stratification in dilated cardiomyopathy - Dr Sanjay
Prasad
Gene therapy for hypertrophic cardiomyopathy: targeting the cause - Prof Lucie Carrier
Pathogenesis of familial restrictive cardiomyopathy - Dr Marco Mongillo
Poster Session (09:30 - 10:00): Abstract Category - Valve disease/pericardial
disease/cardiomyopathy
MDT Live 3 - Heart Failure: Wednesday, 10:45 - 12:15
Moderator: Prof Andrew Clark
Case presentations: Dr Paul David Callan; Dr Parminder Chaggar;
Panel discussion - Panelists: Dr Ceri Davies; Dr Guy MacGowan; Mrs Samantha Breen; Mrs Dawn
Lambert; Dr Geraint Morton




Discussion of evidence/literature
Panel/Audience interaction
Case conclusion
Announcement of the results of the BSH Board Election
CCP Session 2: Wednesday, 10:45 - 12:15
Chair: Mr Alan Keys and Mr Trevor Fernandes
Talks:


Finding all the FH patients in your practice - Prof Steve Humphries
Gene Therapy for the Failing Heart - Dr Alexander Lyon
In addition to these core sessions there are a number of ‘Hot Topic’ Sessions of specific interest
taking place in the Education Hall, Hot Topic - Zone 3 (heart failure, devices, imaging):
 Novel risk stratification markers for HF - Dr Kenneth Wong
 Clinical trials update in heart failure - Prof John Cleland
 Exercise in heart failure: how and why? - Prof Christi Deaton
 Role of TOE in the patient with heart failure - Dr Anita MacNab
 Ultrafiltration in acute heart failure - Dr Peter Cowburn
 Who and when to refer for heart transplantation - Dr Steven Shaw
 Indications for CRT and or ICD therapy in heart failure - Dr Gerald Carr-White
 Optimisation of CRT therapy - Dr Amir Zaidi
 LV non-compaction: diagnosis and management - Prof Steffen Peterson
 Myocarditis: diagnosis and therapy - Dr Christopher Miller
 ARVC: diagnosis and risk stratification - Dr Matthias Schmitt
 Advances in the management of Kawasaki disease - Dr Jane Burns
 Cardiac amyloid/iron and the restrictive cardiomyopathies - Dr Lisa Anderson
 Sodium and water restriction in heart failure - Dr Paul Kalra
 Anticoagulation in heart failure - Dr Lindsey Tilling
 Peripartum cardiomyopathy - Dr Mark Belham
 Respiratory or cardiac dyspnoea? - Dr Piers Clifford
 HF-PEF or obesity? - Dr Mark Petrie
 Imaging in new-onset HF - Dr Andy Flett
 Dilated cardiomyopathy: idiopathic or specific? - Dr Joanne Simpson
 Current clinical role of CMR tissue characterisation - Prof James Moon
 New drugs for HF? - Dr Charlotte Manisty
 Future devices for HF - Dr Stephen Pettit
 Heart failure and COPD, beta-blockers and antagonists - Dr William Bradlow
There is little doubt that there is an increasing - rather than decreasing - need for today's
cardiologists to have a broad understanding of all the major subspecialist areas. The British
Cardiovascular Society Annual Conference is uniquely positioned to provide this in one meeting.
VIEW THE FULL PROGRAMME HERE
Registration: Conference registration is open, with free registration for BCS Members until
29/05/2015. For more on the 2015 Conference please contact the BCS on [email protected]
TEL: 0207 383 3887 or follow us on #BCS2015.
Annual Dinner: now a highlight of the Conference, this year’s dinner will be bigger than ever, with a
champagne reception, 3-course dinner, and a fund raising raffle. Tickets are available for purchase
when registering for the conference.
I hope you have an enjoyable and educationally rewarding time at the 2015 BCS Annual Conference!
Prof Cliff Garratt
Vice-President (Education & Research)
Chair of Programme Committee